BioMEMS devices for drug delivery

  title={BioMEMS devices for drug delivery},
  author={Eric E Nuxoll and Ronald A. Siegel},
  journal={IEEE Engineering in Medicine and Biology Magazine},
  • E. Nuxoll, R. Siegel
  • Published 13 January 2009
  • Biology, Engineering
  • IEEE Engineering in Medicine and Biology Magazine
Successful therapeutic outcomes following the administration of drugs, including small molecules and large biomolecules, require not only the selection of a proper drug but also its delivery to the proper site of action, with proper temporal presentation. Drug delivery is an extremely broad area of research, as each molecule presents its own absorption, distribution, metabolism, excretion, and toxicology (ADMET) profile. Moreover, timing of drug release may affect the efficacy of a… 

Figures from this paper

BioMEMs for drug delivery applications

This chapter discusses the use of biological microelectromechanical systems (bioMEMs) in drug delivery applications to dramatically improve the efficacy of therapeutics by increasing their bioavailability, biodistribution, and by providing technologies of targeted drug delivery, timed drug release, and triggered drug release.

BioMEMS in drug delivery.

  • E. Nuxoll
  • Engineering, Biology
    Advanced drug delivery reviews
  • 2013

Microfluidics for Drug Delivery

Microfluidics is a key enabling technology for these upcoming drug delivery devices that require the precise handling of small liquid volumes using small sized and low energy consuming devices.

Reservoir-based drug delivery systems utilizing microtechnology.

MEMS: Enabled Drug Delivery Systems

The use of MEMS technologies to produce drug delivery devices detailing the delivery mechanisms, device formats employed, and various biomedical applications are presented.

Nanochannel Technology for Constant Delivery of Chemotherapeutics: Beyond Metronomic Administration

The long-term, controlled, zero-order release of low- and high-molecular weight chemotherapeutics through nanochannel membranes is demonstrated by exploiting the molecule-to-surface interactions presented by nanoconfinement.

Drug-releasing implants: current progress, challenges and perspectives.

This review is aimed at highlighting the different types and concepts of drug-releasing implants incorporating new nanomaterials and nanotechnology-based devices, and provides a future perspective in the development of implantable clinical drug-delivery systems based on micro and nantechnology.



Small-scale systems for in vivo drug delivery

Micro- and nanotechnologies are enabling the design of novel methods such as radio-frequency addressing of individual molecules or the suppression of immune response to a release device, but current challenges include the need to balance the small scale of the devices with the quantities of drugs that are clinically necessary.

Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery.

Integrated microsystems for controlled drug delivery.

In vivo release from a drug delivery MEMS device.

Multi-pulse drug delivery from a resorbable polymeric microchip device

Biodegradable polymeric microchips were fabricated that released four pulses of radiolabelled dextran, human growth hormone or heparin in vitro that retained on average 96 ± 12% of its bioactivity.

Microsystems for drug and gene delivery

Recent progress in microdevices for delivering therapeutic agents, including microneedles, DNA transfection schemes, and intravascular drug and gene delivery systems are reviewed.

Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications.

A multistage delivery system that can carry, release over time and deliver two types of nanoparticles into primary endothelial cells is shown, based on biodegradable and biocompatible mesoporous silicon particles that have well-controlled shapes, sizes and pores.

Bioadhesive poly(methyl methacrylate) microdevices for controlled drug delivery.